Kuros Biosciences AG insider transactions
Management transactions
46
Shareholding disclosures
268
First disclosure
29.10.2002
Last disclosure
18.09.2026
Company summary
Over 90 days: 3 purchases (CHF 428 k) and 1 sales (CHF 552 k). Disclosed flows are net selling.
- Latest purchase
- CHF 282’505
- Net flow 90 d
- CHF -123’573
- Top shareholder
- 24.832%
19.10.2026 · Executive member of the board of directors / senior management
Buys − sales
Chris Oomen
This page brings together all Kuros Biosciences AG (CYTOS) insider transactions: 46 management transactions and 268 significant shareholding disclosures published by SIX Exchange Regulation, from 29.10.2002 to 18.09.2026.
Detailed context
Kuros Biosciences AG has recorded 46 management transactions and 268 significant shareholding disclosures published by SIX Exchange Regulation. Within the last 90 days, there were 3 purchases totaling CHF 428'427 and 1 sales transaction amounting to CHF 552'000, with the latest management transaction dated 2026-10-19. The largest declared shareholders by voting rights include Chris Oomen at 24.832%, Optiverder B.V at 24.832%, Clemens van Blitterswijk 2 at 17.64%, and Didier Cowling at 17.64%.
Insider barometer
90 days
4 transactionsCHF -123’573
Net selling
Declared purchases
CHF 428’427
Declared sales
CHF 552’000
Latest transaction
19.10.2026
Largest purchase
CHF 925’210
Largest sale
CHF 8’226’000
These figures aggregate public disclosures. They are not investment advice.
insider24.ch
Follow Kuros Biosciences AG’s disclosures
Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.
Need more? Discover the Pro plan
Kuros Biosciences AG insider transactions
Kuros Biosciences AG
Executive member of the board of directors / senior management · Registered shares
Kuros Biosciences AG
Executive member of the board of directors / senior management · Registered shares
Kuros Biosciences AG
Executive member of the board of directors / senior management · Registered shares
Kuros Biosciences AG
Executive member of the board of directors / senior management · Registered shares
Kuros Biosciences AG
Executive member of the board of directors / senior management · Registered shares
Kuros Biosciences AG
Executive member of the board of directors / senior management · Registered shares
Kuros Biosciences AG
Executive member of the board of directors / senior management · Registered shares
Kuros Biosciences AG
Executive member of the board of directors / senior management · Registered shares
Kuros Biosciences AG
Non-executive member of the board of directors · Registered shares
Kuros Biosciences AG
Executive member of the board of directors / senior management · Registered shares
Latest shareholding disclosures
Kuros Biosciences AG
Swisscanto Fondsleitung AG · Collective investment vehicle
Kuros Biosciences AG
JPMorgan Chase & Co · Single shareholder
Kuros Biosciences AG
JPMorgan Chase & Co · Single shareholder
Kuros Biosciences AG
Bank of America Corporation · Single shareholder
Kuros Biosciences AG
JPMorgan Chase & Co · Single shareholder